Dr. Todd Hankinson
I am originally from Versailles, France and moved to Bethesda, Maryland at the age of 5. Growing up near the NIH, I have developed a long-standing appreciation for the medical sciences. After graduating from St. John’s College High
School in downtown D.C., I studied biochemistry at Salisbury University on the eastern shore, where I also played Division I rugby. Feeling a natural progression to learn about oncology, I moved to England in 2019 and recently completed
an MSc. in Cancer degree from University College London. As an aspiring physician-scientist, I wanted to engage in more translational research experiences before medical school and am currently a junior professional research assistant
in the Hankinson Lab.
Keanu C.K.K.W. CheeI was born and raised in Hawai’i, and am very fortunate for the opportunity to attend medical school at the University of Colorado School of Medicine. I completed my undergraduate studies in exercise physiology and Chemistry at Oregon State University. Prior to starting medical school in 2019, I fulfilled a research position studying bladder cancer at the University of Hawai’i Cancer Research Center working to develop a multiplex assay to detect cancer by utilizing different biomarkers in urine. In the Hankinson Lab at the University of Colorado, we have the unique opportunity to work with teams across the globe to study Adamantinomatous Craniopharyngiomas (ACP) in the pediatric population. As an aspiring neurosurgeon, my interests within the field include neuro-oncology and functional neurosurgery.
My current projects include establishing a model for growing immune cells in culture and exposing them to cyst fluid to determine its effects on cells, as well as looking into to developing an ACP cell line from induced-pleuripotent stem cells which can potentially be derived from tumor epithelial cells. Outside of medicine, my hobbies include running, hiking, and playing the guitar.
Eric PrinceMy research interest is primarily focused on the application of machine learning and artificial intelligence in the context of rare brain tumors across the wide array of modern biomedical data. Through utilizing AI, we can advance the field of medicine and healthcare in countless and highly translational ways. While one AI algorithm can aid in predictive diagnostics to give radiologists statistical metrics to help better consult their patients, another AI algorithm can be used to identify genomic features in a given patient that can lend itself to enhanced precision medicine. At my position in the Hankinson lab, I study the rare brain tumor Adamantinomatous Craniopharyngioma (ACP). Thanks to the collaborating members of the Advancing Treatment for Pediatric Craniopharyngioma consortium we have access to a comprehensive dataset comprised of genomics and clinical imaging. I like to spend my free time in the mountains, typically snowboarding, cycling, or camping. I also enjoy checking out the various excellent craft breweries that Colorado has to offer!
I am the project manager for Dr. Hankinson’s national Advancing Treatment for Pediatric Craniopharyngioma Consortium (ATPC) and work with the participating sites to obtain tissue and clinical data as well as work with our local patients and families here in Colorado.